Skip to main content
. 2019 Jan 21;11(1):122. doi: 10.3390/cancers11010122
GBM glioblastoma
WHO World Health Organization
TMZ temozolomide
LTS long-term survivor
NSC neural stem cell
NPC neural progenitor cell
SVZ subventricular zone
PFS progression-free survival
OS overall survival
IDH1 isocitrate dehydrogenase 1
CEL contrast-enhancing lesion
KPS Karnofsky performance score
GTR gross total resection
EOR extent of resection
STS short-term survivor
MGMT O6-methylguanin-DNA-methyltransferase
CE contrast-enhancing
T1-w T1-weighted
FLAIR fluid-attenuated inversion recovery
RT radiotherapy
HR hazard ratio
CI confidence intervall
PACS Picture Archiving and Communication System
RANO Response Assessment in Neuro-Oncology
MPRAGE magnetization-prepared rapid gradient-echo